Safety and Clinical Activity of Multiple Doses of Barzolvolimab, an anti-KIT Antibody, in Patients with Chronic Spontaneous Urticaria

被引:0
作者
Maurer, Marcus [1 ]
Metz, Martin [1 ]
Anderson, John [2 ,3 ]
Talreja, Neetu [4 ]
Windom, Hugh [5 ,6 ]
Alvarado, Diego [7 ]
Crowley, Elizabeth [7 ]
Young, Diane [7 ]
Merchant, Kunal [7 ]
Paradise, Elsa [7 ]
Heath-Chiozzi, Margo [7 ]
Bernstein, Jonathan [8 ,9 ]
机构
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] AlIerVie Hlth, Birmingham, AL USA
[4] Allergy Grp & Treasure Valley Med Res, Boise, ID USA
[5] Univ S Florida, Sarasota, FL USA
[6] Windom Allergy Asthma Sinus, Sarasota, FL USA
[7] Celldex Therapeut, Hampton, NJ USA
[8] Univ Cincinnati, Cincinnati, OH USA
[9] Bernstein Allergy Grp Clin Res Ctr, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
410
引用
收藏
页码:AB133 / AB133
页数:1
相关论文
共 50 条
  • [31] Clinical characteristics of 197 patients with chronic spontaneous urticaria in the Bulgarian population
    Valerieva, A.
    Staevska, M.
    Petkova, E.
    Kralimarkova, T.
    Lazarova, T.
    Dimitrov, V
    Popov, T.
    ALLERGY, 2015, 70 : 153 - 153
  • [32] Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients
    Ghazanfar, M. N.
    Sand, C.
    Thomsen, S. F.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) : 404 - 406
  • [33] Efficacy and safety of active vitamin D supplementation in chronic spontaneous urticaria patients
    Mohamed, Amal Ahmed
    Hussein, Maha S.
    Salah, Eman Mohamed
    Eldemery, Ahmed
    Darwish, Mona Mohamed
    Ghaith, Doaa M.
    Attala, Rasha A.
    El Borolossy, Radwa
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 427 - 432
  • [34] Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
    Michihiro, Hide
    Hae-Sim, Park
    Atsuyuki, Igarashi
    Young-Min, Ye
    Tae-Bum, Kim
    Akiko, Yagami
    Jooyoung, Roh
    Jae-Hyun, Lee
    Yuko, Chinuki
    Woong, Youn Sang
    Soo-Keol, Lee
    Naoko, Inomata
    Jeong-Hee, Choi
    Atsushi, Fukunaga
    Junyi, Wang
    Soichiro, Matsushima
    Steve, Greenberg
    Sam, Khalil
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 87 (01) : 70 - 78
  • [35] Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients Reply
    Balp, Maria-Magdalena
    Weller, Karsten
    Carboni, Veruska
    Chirilov, Alexandra
    Papavassilis, Charis
    Severin, Thomas
    Tian, Haijun
    Zuberbier, Torsten
    Maurer, Marcus
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (06) : 670 - 671
  • [36] Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19
    Passante, Maria
    Napolitano, Maddalena
    Dastoli, Stefano
    Bennardo, Luigi
    Fabbrocini, Gabriella
    Nistico, Steven Paul
    Patruno, Cataldo
    DERMATOLOGIC THERAPY, 2021,
  • [37] Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria
    Castagna, J.
    Bernard, L.
    Hacard, F.
    Delcroix, F.
    Darrigade, A. -S.
    Nicolas, J. -F.
    Decullier, E.
    Nosbaum, A.
    Berard, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (06) : 1124 - 1126
  • [38] The Comparative Safety of Multiple Alternative Agents in Refractory Chronic Urticaria Patients
    Seth, Sharon
    Khan, David A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (01) : 165 - +
  • [39] IgE anti-TPO as a biomarker of different clinical phenotypes in chronic spontaneous urticaria
    Sanchez, J.
    Sanchez, A.
    Cardona, R.
    ALLERGY, 2019, 74 : 479 - 479
  • [40] The Urticaria Control Test and Urticaria Activity Score correlate with quality of life in adult Japanese patients with chronic spontaneous urticaria
    Nakatani, Shoko
    Oda, Yoshiko
    Washio, Ken
    Fukunaga, Atsushi
    Nishigori, Chikako
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (02) : 279 - 281